Urinalysis Market Size To Reach USD 2.14 Billion By 2022

Posted September 10, 2020 by sitakant

Global urinalysis market is expected to reach over USD 2.14 billion by 2022, according to a new report by Grand View Research, Inc.

Global urinalysis market is expected to reach over USD 2.14 billion by 2022, according to a new report by Grand View Research, Inc.
Automation is a key technological advancement affecting the efficiency and accuracy delivered by the new generation urinalysis devices and hence, the persistent demand for novel urinalysis instruments and consumables. For instance, the automatic bench-top and portable biochemical urine analyzers, automated urine sediment analyzers (Aution Hybrid AU-4050 from Arkray),and automated microscopic urine analyzers (Sysmex UF-1000i) are the next generation, advanced instruments is anticipated to foster the urinalysis market growth.
For PDF sample Copy or More Details please visit link @: http://www.grandviewresearch.com/industry-analysis/urinalysis-market
The introduction of CLIA-waived urine reagent strips such as CLIA-URS-10, CLIA-URS-10-3PROMO, and CLIA-URS-10-10 provide for an effective screening tool for rapid testing in urine analysis which are estimated to enhance the usage rates of urinalysis reagents thus accentuating the market growth over the forecast period.
The target population base for urinalysis market is increasing owing to, factors such as the rising prevalence of target diseases, misdiagnosis, and low awareness levels pertaining to urine analysis in low-income countries. High incidences of obesity coupled with hypertension, diabetes, and other chronic disorders foster the growth of the urinalysis market.
Further key findings from the study suggest:
• Urinary Tract Infections (UTIs)dominated the application segment in 2014. The foremost factor responsible for its high share is the rising prevalence of UTIs, especially in females. However, diabetes is estimated to be the fastest growing application segment with a CAGR of over 10% during the forecast period owing to a surge in the demand for automated and user-friendly urinalysis products for long-term diabetes management.
• Consumables held the largest share with revenue generation of over USD 1 million in 2014. The increasing usage of test strips and reagents for urinalysisis one of the major factors that are attributed to its large market share. However, the instrument segment is expected to witness the fastest growth with a CAGR of over 7%. Automation of instruments with improved efficiency and reliability is expected to govern this segment’s growth.
• The home healthcare segment, on the other hand, is anticipated to grow at a substantial rate over 7.5%. The availability of technologically enabled point-of-care urinalysis systems, such as CLINITEK Status, is a key factor expected to reinforce the market growth.
• North America dominated the overall urinalysis market with a revenue generation of over USD 540 million in 2014. The introduction of advanced urine analyzers by key market players in the U.S., favorable government initiatives ensuring the betterment of healthcare testing, and the high amount of healthcare spending in this region are the key factors attributing to the largest market share of this region.
• Key players of this market include Roche Diagnostics, Alere, Inc., Siemens Healthcare, Bio-Rad, ARKRAY, Inc., Mindray, and Sysmex.
• Market participants are constantly engaged in the introduction of novel diagnostic products in an attempt to ensure their sustainability and increase the penetration of their product portfolio. For instance, in June 2014, Roche launched a fully automated urine testing analyzer named Cobas 6500 with an objective to enhance staff safety and increase the result reliability.
To request research report sample copy with TOC please visit @: https://www.grandviewresearch.com/industry-analysis/urinalysis-market/request/rs1
Grand View Research has segmented the global urinalysis market on the basis of product, application, end-use, and region:
Global Urinalysis Product Outlook (Revenue, USD Million, 2015 - 2022)
• Instruments
o Biochemical urine analyzers
o Automated biochemical analyzers
o Semi-automated biochemical analyzers
o Automated urine sediment analyzers
o Microscopic urine analyzers
o Flow-cytometric urine analyzers
• Consumables
o Dipsticks
o Reagents
o Disposables
Global Urinalysis Application Outlook (Revenue, USD Million, 2015 - 2022)
• UTIs
• Diabetes
• Kidney Disease
• Hypertension
• Liver disease
• Others
Global Urinalysis End-use Outlook (Revenue, USD Million, 2015 - 2022)
• Hospitals
• Clinical Laboratories
• Home healthcare
• Research and academics
• Others
Urinalysis Regional Outlook (Revenue, USD Million, 2015 - 2022)
• North America
o U.S.
o Canada
• Europe
o U.K
o Germany
• Asia Pacific
o Japan
o China
• Latin America
o Brazil
o South Africa
For Inquire before buying please visit @: https://www.grandviewresearch.com/inquiry/1446/ibb
About Grand View Research
Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S.-based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By sitakant
Country United States
Categories Business , Health
Tags urinalysis market size
Last Updated September 10, 2020